TubelessInsulin Pump Market, by Component (Pod/Patch, Remote, and Accessories), andby End User (Hospitals, Pharmacies, and E-Commerce) - Global Industry Insights,Trends, Outlook, and Opportunity Analysis 2018-2026
Tubeless insulin pump is aportable pump, which is effective in controlling blood glucose level.Advancements in technologies of insulin pumps, which reduce the need for dailyinsulin injection doses is expected to boost growth of the tubeless insulinpump market over the forecast period. Omnipod, by Insulet Corporation isexpected to drive the growth of insulin pumps in near future. Omnipod is anovel tubeless insulin pump, which displays blood glucose levels, schedulesinsulin delivery, and calculates optimal insulin dosage based on food database.Furthermore, Insulet Corporation has recently added additional features such astouchscreen and Bluetooth to Omnipod Dash system. Portability offered by thesedevices permits easy attachment and placements of the device on clothing ordesired body parts, which is expected to drive growth of the tubeless insulinpump market.
Increasing funding by thegovernment for studying various diseases including diabetes is also expected tofuel growth of the tubeless insulin pump market. For instance, in 2013,National Institute of Diabetes and Digestive and Kidney Disease (NIDDK) fundedseveral important studies on different types of artificial pancreas devices tohelp patients suffering from type 1 and type 2 diabetes and gestationaldiabetes. Insulin pumps have gained traction, owing to the rapid actingmechanism offering instant insulin delivery, user friendly interface, andflexible insulin delivery, which is expected to fuel growth of the tubelessinsulin pump market over the forecast period.
* The sample copy includes: Report Summary, Table ofContents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copyof this report: https://www.coherentmarketinsights.com/insight/request-sample/1298
Increasing prevalence of diabetesand robust development in technology is expected to drive growth of the marketover the forecast period
Increasing prevalence of diabetesdue to obesity and increasing geriatric population is driving demand fortubeless insulin pump market. According to the World Health Organization, 2016,an estimated 422 million adults were suffering from diabetes globally. Newtechnologies incorporated into tubeless insulin pump devices is leading toincreasing demand for insulin pump devices worldwide. Market players arefocused on developing new technologies in tubeless insulin pump devices, whichcan be used at home with ease and with accurate results, this in turn isexpected to boost overall market growth during the forecast period. Forinstance, in 2016, in the U.K., Medtrum Technologies, Inc. launched S6Easysense Disposable CGM System, which provides interstitial glucose levels inevery two minutes and P6 Tubeless Patch Pump, which is ideal for type 2diabetes management and gestational diabetes. It also allows monitoring of datausing mobile app. However, high long-term cost associated with the use oftubeless insulin pump hampers the market growth. Compliance to therapy reducesover the time, owing to significant cost associated with daily use.
Browse ResearchReport: https://www.coherentmarketinsights.com/ongoing-insight/tubeless-insulin-pump-market-1298
On the basis of geography, NorthAmerica is expected to dominate the tubeless insulin pump market, followed byEurope, owing to high adoption rate for new technology and continuousgovernment initiatives to create awareness regarding diabetes. For instance, in2016, the American Diabetes Association (ADA) recommended diabetes education,training on the device, and providing support after prescription of ContinuousGlucose Monitoring (CGM) and insulin pump. Market in Asia Pacific is lucrativein terms of market opportunities due to increase in research and developmentactivities by various vendors and implementation of government initiatives fordiabetic patients. For instance, in 2017, National Diabetes Services Scheme(NDSS) initiated by Australian Government funded Insulin Pump Programme toincrease the affordability of insulin pumps to for people suffering from type 1diabetes who don’t have access to private health insurance.
Major players operating in thetubeless insulin pump market include Medtronic Plc., Medtrum Technologies,Inc., Tandem Diabetes Care, Insulet Corporation, and Animas Corporation.
Buy-Now this researchreport: https://www.coherentmarketinsights.com/insight/buy-now/1298
AboutCoherent Market Insights:
CoherentMarket Insights is a prominent market research and consulting firm offeringaction-ready syndicated research reports, custom market analysis, consultingservices, and competitive analysis through various recommendations related toemerging market trends, technologies, and potential absolute dollaropportunity.
ContactUs:
mailto:sales@coherentmarketinsights.com
U.S.Office:
Name: Mr. Shah
CoherentMarket Insights 1001 4th Ave,
# 3200Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN: +050-5539-1737
